Dimensional Fund Advisors LP Rocket Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 760,941 shares of RCKT stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

760,941

Previous 912,605 16.62%

Holding current value

$7.01 Million

Previous $16.9 Million 43.25%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$11.35 - $18.82 $1.72 Million - $2.85 Million	-151,664 Reduced 16.62%	760,941 $9.57 Million
Q3 2024 Nov 07, 2024	SELL	$17.6 - $25.88 $590,832 - $868,791	-33,570 Reduced 3.55%	912,605 $16.9 Million
Q2 2024 Aug 09, 2024	SELL	$20.66 - $26.72 $1.73 Million - $2.23 Million	-83,613 Reduced 8.12%	946,175 $20.4 Million
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $474,882 - $558,023	-18,153 Reduced 1.73%	1,029,788 $27.7 Million
Q4 2023 Feb 07, 2024	SELL	$16.78 - $31.94 $4.84 Million - $9.22 Million	-288,731 Reduced 21.6%	1,047,941 $31.4 Million
Q3 2023 Nov 09, 2023	SELL	$15.07 - $24.05 $37,479 - $59,812	-2,487 Reduced 0.19%	1,336,672 $27.4 Million
Q2 2023 Aug 09, 2023	BUY	$16.59 - $23.6 $1.11 Million - $1.57 Million	66,665 Added 5.24%	1,339,159 $26.6 Million
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $2.28 Million - $3.26 Million	144,133 Added 12.77%	1,272,494 $21.8 Million
Q4 2022 Feb 09, 2023	BUY	$15.5 - $22.76 $3.79 Million - $5.57 Million	244,792 Added 27.7%	1,128,361 $22.1 Million
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $5.52 Million - $8.22 Million	446,574 Added 102.19%	883,569 $14.1 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $172,970 - $361,587	21,730 Added 5.23%	436,995 $6.01 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $379,350 - $682,599	28,826 Added 7.46%	415,265 $6.59 Million
Q4 2021 Feb 09, 2022	BUY	$21.52 - $36.02 $257,874 - $431,627	11,983 Added 3.2%	386,439 $8.44 Million
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $3.37 Million - $6.02 Million	-122,854 Reduced 24.7%	374,456 $11.2 Million
Q2 2021 Aug 12, 2021	BUY	$39.41 - $47.25 $7.45 Million - $8.93 Million	189,020 Added 61.31%	497,310 $22 Million
Q1 2021 May 14, 2021	SELL	$43.34 - $65.91 $1.2 Million - $1.83 Million	-27,716 Reduced 8.25%	308,290 $13.7 Million
Q4 2020 Feb 25, 2021	BUY	$23.3 - $59.57 $7.83 Million - $20 Million	336,006 New	336,006 $18.4 Million

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $697M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Rocket Pharmaceuticals, Inc. Transaction History